HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan’s Switch Committee Resists Full Reform

Executive Summary

Japan’s Rx-to-OTC Switching Evaluation Committee has accepted most of the reforms mandated by the country’s government as part of its attempt to reform the national medicines reclassification system. However, it still has more of a role than industry would perhaps like. 

You may also be interested in...



Seven-Year Legal Challenge To Japan’s OTC Online Sales Ban Fails

Japan’s Supreme Court has delivered a final ruling on a seven year dispute over online sales of non-prescription medicines. The Court has rejected a complaint against the ban on distant selling of OTCs in the most-strictly-regulated category, that of recently switched drugs. Meanwhile, the Japanese government is extending the country’s Self-Medication Tax Deduction System for another five years.

Japan Embarks On Rx-To-OTC Switch Revolution

The Japanese government has approved a raft of measures aimed at expanding the country's consumer health market, including reforms to an Evaluation Committee that has not lived up to its promise of expediting Rx-to-OTC switches. 

ADM Protexin Launches Vitamin-Enriched Probiotic, Investigates Gut-Brain Axis

To help brighten up summer for UK consumers,  ADM Protexin has added a vitamin-enriched food supplement to its Bio-Kult line of probiotics. The firm also profiles a recent clinical trial showing promise for probiotic-related mood improvement in a short documentary. 

Topics

UsernamePublicRestriction

Register

RS151407

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel